SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is discussing the rapid collapse of the newly launched $LAPTOP.X meme coin, with traders widely characterizing the event as a significant rug pull. Many express frustration and skepticism regarding its extreme volatility, with some observers comparing the token's performance to other politically-themed cryptocurrencies.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devon Energy is trending as investors analyze the impact of rising oil prices and heightened geopolitical tensions in the Middle East on the company's valuation. While some traders are bullish on its Permian Basin position and free cash flow potential, others remain skeptical, citing concerns about stock price suppression and market manipulation despite strong commodity prices.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is experiencing volatility that has sparked intense debate, with some traders debating potential price floors and recovery prospects, while others derisively label it a "trash" asset and call for further declines. The conversation is dominated by skeptical retail traders mocking long-term holders as "suckers" for failing to take profits, amidst a backdrop of bearish sentiment and overall lack of consensus on the token's future.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending following news that Executive Chairman Larry Ellison has canceled his previously disclosed plan to sell up to 50 million shares. While some investors interpret this as a bullish sign that strengthens the stock's long-term outlook, others express frustration over the company's high capital expenditure and debt levels.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech shares are experiencing volatility following a disappointing quarterly earnings report, reduced revenue guidance, and the announcement that the company's co-founders will depart at the end of the year to launch a new venture.

Anthropic

Anthropic is generating significant market interest and controversy, primarily driven by the upcoming IPO, substantial infrastructure deals, and concerns surrounding the security capabilities of its advanced AI models like Mythos. Traders are actively debating the company's valuation, potential competitive threats, and the impact of its rapid scaling on the broader tech sector.

Pump.fun

PUMP is trending as traders debate its market performance, with some pointing to its revenue generation and token buyback mechanism as catalysts for potential long-term growth, while others dismiss it as a "pump and dump" scheme. The conversation is characterized by sharp disagreement between participants labeling it a hidden gem and those warning of rampant scams and volatility within the platform's ecosystem.

Pons

PONS is experiencing significant volatility as market participants debate its price direction and monitor the liquidations of large short positions. Discussions are further fueled by the ecosystem's expansion, specifically the introduction of new related tokens that reward holders with transaction fee distributions.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as traders speculate on a potential buyout and anticipate upcoming clinical data for its IgAN drug, Trutakna. The discussion is driven by high short interest and institutional accumulation, with the community closely watching for phase 3 eGFR readout and further commercial rollout updates.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent BioSolutions is trending as traders speculate on potential institutional accumulation and activist interest following a $75 million note buyback. While some investors remain bearish due to debt levels and commercial competition, others are optimistic about a potential short squeeze and future biodefense contract awards.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DeGeerO

TheDudeAbides

Dale Williams

$SNDL im out until theres clarity on the RS. done playing these games where they leave shareholders in the dark. Still have some leaps which are so underwater ill leave them for a miracle. Seems like its q after q of subpar earnings while they burn cash and stock price goes down